Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines-Reference-Cited by-同舟云学术

Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines

Published:2024-05 Issue:2 Volume:19 Page:268-276
ISSN:1574-8863
Container-title:Current Drug Safety
language:en
Short-container-title:CDS

Author:

Moukafih Badreddine¹^ORCID,Belaroussi Leila²,Achour Sanae³,Kartouti Abdeslam El⁴

Affiliation:

1. Central Pharmacy Department, CHU Hassan II, Medical Center for Biomedical and Translational Research, Faculty of Medicine, Pharmacy and dentistry of Fez, Sidi Mohammed Ben Abdellah University, Fez, Morocco

2. Occupational Health Department, CHU Hassan II-Fez, Epidemiology and Health Sciences Research Laboratory, Faculty of Medicine and Pharmacy of Fez, Sidi Mohammed Ben Abdellah University, Fez, Morocco

3. Toxicology Department, CHU Hassan II, Fez, Medical Center for Biomedical and Translational Research, Faculty of Medicine, Pharmacy and Dentistry of Fez, Sidi Mohammed Ben Abdellah University, Morocco Hospital, Fez, Morocco

4. Pharmacy Service, Moulay Ismaïl Military Hospital, Meknès, Medical Center for Biomedical and Translational Research, Faculty of Medicine, Pharmacy and Dentistry of Fez, Sidi Mohammed Ben Abdellah University, Fez, Morocco

Abstract

Background: Low confidence in the safety of COVID-19 vaccines was found to be a key promoter of vaccine reluctance especially among youth. Furthermore, young adults are an important demographic for building herd immunity through vaccination. As a result, their reactions to getting COVID-19 vaccines are crucial in our fight against SARS-CoV-2. Objective: The overall goal of this study was to look into the shortterm side effects experienced by Moroccan medical and pharmacy students after receiving COVID-19 vaccines. Methods: A cross-sectional survey-based study to assess the COVID-19 vaccines' short-term AEFIs among Moroccan medical and pharmacy students. The validated questionnaire was delivered in a digital form to explore the side effects (SE) they encountered after the first or the second dose of one of three vaccines namely: AstraZeneca Vaxzevria, PfizerBioNTeck, and SinoPharm vaccines. Results: There were 510 students in total who took part. After the first and second doses, approximately 72 percent and 78 percent of subjects, respectively, reported no SE. The remainder had localized injection site side effects (26%). Fatigue (21%), fever (19%), headache (17%), and myalgia (16%) were the most common systemic adverse effects after the first dose. There were no serious SEs reported. Conclusion: The majority of the reported AEFIs in our data were mild to moderate in intensity and lasted only one or two days. COVID-19 vaccinations are highly likely safe for young adults, according to the findings of this study.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference67 articles.

1. Attia S.; Howaldt H.P.; Impact of COVID-19 on the dental community: Part I before Vaccine (BV). J Clin Med 2021,10(2),288

2. Leidner A.J.; Murthy N.; Chesson H.W.; Cost-effectiveness of adult vaccinations: A systematic review. Vaccine 2019,37(2),226-234

3. Gavi the Vaccine Alliance. There are Four Types of COVID-19 Vaccines: Here’s How They Work. Available from:

4. MacDonald N.E.; Eskola J.; Liang X.; Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015,33(34),4161-4164

5. Strategic Advisory Group of Experts on Immunization (SAGE) Vaccine Hesitancy Survey Questions Related to SAGE Vaccine Hesitancy Matrix Available from: